[Skip to Content]
[Skip to Content Landing]
Citations 0
Health Agencies Update
November 21, 2001

FDA Cannot Ensure Overseas Protections

Author Affiliations
 

Not Available

Not Available

JAMA. 2001;286(19):2390. doi:10.1001/jama.286.19.2390

As the number of overseas clinical trials supported by US companies swells, the FDA cannot ensure patient safety in these studies, according to a report by the Department of Health and Human Services.

During the past decade the number of foreign researchers providing data to the FDA for new drug applications increased 1600%. The number of countries supplying patients for research required by the FDA also surged, from 28 in 1990 to 79 in 1999. Latin America and Eastern Europe, including Russia, account for much of the expansion.

First Page Preview View Large
First page PDF preview
First page PDF preview
×